Conflicts of interests:
Kirsten Beyer reports advisory board/consulting fees or speakers bureau
from Aimmune Therapeutics, Bencard, Danone/Nutricia, DBV, Hycor,
Infectopharm, Mabylon, Meda Pharma/Mylan, Nestle, Novartis and
ThermoFisher as well as research grants from Aimmune, ALK,
Danone/Nutricia, DBV Technologies, Hipp, Hycor, Infectopharm and
Novartis outside the submitted work. Birgit Kalb reports advisory
board/consulting fees from Viatris. Valérie Trendelenburg received
speaker’s fees from Nutricia/Danone. Friederike Bluhme, Stephanie Heller
and Lara Meixner have nothing to disclose.
Financial support: This study was funded in part by the
Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) as
part of the clinical research unit (CRU339): Food allergy and tolerance
(FOOD@) – 409525714.